Oruka Therapeutics, Inc. (ORKA)

SEC filing

Oruka Therapeutics, Inc.

ORKA · CIK 907654

4 · Sep 21, 2026 · General Counsel Quinlan Paul T sold 10K shares at $93.64/share ($936.4K); exercised options for 20K shares

General Counsel Quinlan Paul T sold 10K shares at $93.64/share ($936.4K); exercised options for 20K shares

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).

4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESform4.xml
Open SEC.gov